Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2022 Feb 28:2022:8567642.
doi: 10.1155/2022/8567642. eCollection 2022.

Prognostic Value of NOX4 Expression in Cancer Patients: A Systematic Review and Meta-analysis

Affiliations
Meta-Analysis

Prognostic Value of NOX4 Expression in Cancer Patients: A Systematic Review and Meta-analysis

Hyun Min Koh et al. Dis Markers. .

Abstract

Background: Recent studies have shown that nicotinamide adenosine dinucleotide phosphate oxidase 4 (NOX4) is related to cancer development, proliferation, invasion, epithelial-to-mesenchymal transition, and metastasis. The prognostic value of NOX4 expression although has been reported in various cancers, it remains unclear as several studies have reported conflicting results. Therefore, the purpose of this study was to systematically investigate the prognostic value of NOX4 expression in cancer patients.

Method: Appropriate studies were collected by searching the PubMed, EMBASE, and Cochrane library databases, and the prognostic value of NOX4 expression in cancer patients was assessed through a meta-analysis.

Results: Nine eligible studies involving 2675 cancer patients were included in this meta-analysis. We found that NOX4 expression is related to prognosis in cancer patients. In particular, high expression of NOX4 was significantly associated with overall survival in patients with gastrointestinal cancer (hazard ratio [HR]: 1.83, 95% confidence interval [CI]: 1.39-2.42, p < 0.001).

Conclusion: NOX4 expression is significantly correlated with overall survival in patients with gastrointestinal cancer, indicating that it could be a potential prognostic marker.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing financial interests.

Figures

Figure 1
Figure 1
Flow diagram of study collection.
Figure 2
Figure 2
Forest plot of the association between NOX4 expression and overall survival.
Figure 3
Figure 3
Forest plot of the association between NOX4 expression and overall survival stratified by cancer type (a), sample size (b), NOX4 detection method (c), and survival analysis (d).
Figure 4
Figure 4
Forest plot of the association between NOX4 expression and disease-free survival.
Figure 5
Figure 5
Forest plot of the association between NOX4 expression and disease-free survival stratified by cancer type (a) and sample size (b).
Figure 6
Figure 6
Funnel plot of the association between NOX4 expression and overall survival (a) or disease-free survival (b).
Figure 7
Figure 7
Sensitivity analysis of the association between NOX4 expression and overall survival (a) or disease-free survival (b).

References

    1. Prasad S., Gupta S. C., Tyagi A. K. Reactive oxygen species (ROS) and cancer: role of antioxidative nutraceuticals. Cancer Letters . 2017;387:95–105. doi: 10.1016/j.canlet.2016.03.042. - DOI - PubMed
    1. Brandes R. P., Weissmann N., Schröder K. Nox family NADPH oxidases: molecular mechanisms of activation. Free Radical Biology and Medicine . 2014;76:208–226. doi: 10.1016/j.freeradbiomed.2014.07.046. - DOI - PubMed
    1. Tang C. T., Gao Y. J., Ge Z. Z. NOX4, a new genetic target for anti-cancer therapy in digestive system cancer. Journal of Digestive Diseases . 2018;19(10):578–585. doi: 10.1111/1751-2980.12651. - DOI - PubMed
    1. Peshavariya H. Editorial (thematic issue: NADPH oxidase-derived ROS signaling and therapeutic opportunities) Current Pharmaceutical Design . 2015;21(41):5931–5932. doi: 10.2174/1381612822999151105125230. - DOI - PubMed
    1. Chen Y., Lu H., Lo C., Hsiao C., Li S. NOX4 overexpression is a poor prognostic factor in patients undergoing curative esophagectomy for esophageal squamous cell carcinoma. Surgery . 2020;167(3):620–627. doi: 10.1016/j.surg.2019.11.017. - DOI - PubMed